The treatment regimen is Furmonertinib combined with Bevacizumab.: clinical trials recruiting now
Fewer than 3 recruiting trials found.
1
Recruiting trials
6
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 2 1
Conditions being studied
| Condition | Trials |
|---|---|
| Brain Metastases | 1 |
| EGFR Mutation-Positive Lung Cancer | 1 |
| Intracranial Tumor Progression | 1 |
| Leptomeningeal Metastases | 1 |
| Lung cancer | 1 |
| Non-small Cell Lung Cancer (NSCLC) | 1 |
Recruiting trials involving The treatment regimen is Furmonertinib combined with Bevacizumab.
Common questions
How many recruiting trials involve The treatment regimen is Furmonertinib combined with Bevacizumab.?
1 recruiting trial across 6 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.